Bison Wealth’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-11,381
| Closed | -$465K | – | 363 |
|
|
2024
Q3 | $465K | Buy |
11,381
+151
| +1% | +$6.18K | 0.07% | 248 |
|
|
2024
Q2 | $481K | Hold |
11,230
| – | – | 0.08% | 248 |
|
|
2024
Q1 | $481K | Sell |
11,230
-14
| -0.1% | -$577 | 0.08% | 248 |
|
|
2023
Q4 | $417K | Sell |
11,244
-817
| -7% | -$29.3K | 0.07% | 260 |
|
|
2023
Q3 | $437K | Sell |
12,061
-136
| -1% | -$4.83K | 0.08% | 236 |
|
|
2023
Q2 | $435K | Buy |
12,197
+189
| +2% | +$6.78K | 0.08% | 242 |
|
|
2023
Q1 | $436K | Buy |
12,008
+55
| +0.5% | +$1.92K | 0.14% | 162 |
|
|
2022
Q4 | $420K | Buy |
11,953
+46
| +0.4% | +$1.53K | 0.13% | 170 |
|
|
2022
Q3 | $350K | Buy |
+11,907
| New | +$451K | 0.14% | 186 |
|
|
2022
Q2 | – | Sell |
-9,702
| Closed | -$528K | – | 338 |
|
|
2022
Q1 | $528K | Buy |
9,702
+2,372
| +32% | +$129K | 0.27% | 102 |
|
|
2021
Q4 | $404K | Buy |
7,330
+220
| +3% | +$11.4K | 0.24% | 114 |
|
|
2021
Q3 | $340K | Buy |
7,110
+128
| +2% | +$6.43K | 0.16% | 161 |
|
|
2021
Q2 | $348K | Sell |
6,982
-5,200
| -43% | -$250K | 0.15% | 167 |
|
|
2021
Q1 | $543K | Sell |
12,182
-640
| -5% | -$29K | 0.23% | 107 |
|
|
2020
Q4 | $590K | Buy |
12,822
+384
| +3% | +$17.6K | 0.28% | 87 |
|
|
2020
Q3 | $585K | Sell |
12,438
-800
| -6% | -$40.1K | 0.34% | 77 |
|
|
2020
Q2 | $675K | Buy |
13,238
+320
| +2% | +$16.4K | 0.43% | 62 |
|
|
2020
Q1 | $612K | Sell |
12,918
-453
| -3% | -$24.2K | 0.44% | 61 |
|
|
2019
Q4 | $785K | Buy |
13,371
+1,720
| +15% | +$95.7K | 0.38% | 67 |
|
|
2019
Q3 | $622K | Buy |
11,651
+1,129
| +11% | +$58.1K | 0.35% | 73 |
|
|
2019
Q2 | $526K | Buy |
10,522
+1,987
| +23% | +$99.7K | 0.31% | 89 |
|
|
2019
Q1 | $446K | Buy |
8,535
+1,072
| +14% | +$53.6K | 0.27% | 111 |
|
|
2018
Q4 | $356K | Sell |
7,463
-394
| -5% | -$19.4K | 0.26% | 114 |
|
|
2018
Q3 | $395K | Buy |
7,857
+1,552
| +25% | +$78.9K | 0.26% | 117 |
|
|
2018
Q2 | $318K | Buy |
6,305
+248
| +4% | +$12.5K | 0.24% | 133 |
|
|
2018
Q1 | $296K | Buy |
6,057
+251
| +4% | +$11.7K | 0.23% | 134 |
|
|
2017
Q4 | $257K | Sell |
5,806
-152
| -3% | -$7.02K | 0.19% | 150 |
|
|
2017
Q3 | $302K | Sell |
5,958
-160
| -3% | -$8.12K | 0.24% | 121 |
|
|
2017
Q2 | $330K | Sell |
6,118
-872
| -12% | -$46.5K | 0.27% | 101 |
|
|
2017
Q1 | $368K | Buy |
6,990
+343
| +5% | +$17.4K | 0.32% | 89 |
|
|
2016
Q4 | $320K | Buy |
6,647
+161
| +2% | +$7.95K | 0.27% | 104 |
|
|
2016
Q3 | $350K | Sell |
6,486
-285
| -4% | -$15.6K | 0.3% | 89 |
|
|
2016
Q2 | $367K | Sell |
6,771
-680
| -9% | -$35.8K | 0.22% | 122 |
|
|
2016
Q1 | $378K | Sell |
7,451
-6,291
| -46% | -$313K | 0.24% | 116 |
|
|
2015
Q4 | $693K | Buy |
13,742
+5,009
| +57% | +$255K | 0.4% | 80 |
|
|
2015
Q3 | $420K | Buy |
8,733
+848
| +11% | +$44.1K | 0.28% | 118 |
|
|
2015
Q2 | $411K | Sell |
7,885
-12,954
| -62% | -$729K | 0.24% | 125 |
|
|
2015
Q1 | $826K | Buy |
+20,839
| New | +$1.19M | 0.5% | 60 |
|
Other funds holding GSK
JEST
Bison Wealth's GSK Position: Q4 2024 in Review
Bison Wealth sold out of GSK (GSK) in Q4 2024, closing a stake of 11,381 shares — an estimated $465K sold.
Bison Wealth first reported a position in GSK in Q1 2015 and held it in 38 quarters. The position peaked at $826K in Q1 2015. 849 funds tracked by Wall St. Rank hold GSK as of Q4 2024.
- Bison Wealth reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
- Bison Wealth sold 11,381 GSK shares in Q4 2024, an estimated $465K.
- Bison Wealth first reported a position in GSK in Q1 2015 and held it in 38 quarters.
- Bison Wealth's GSK position peaked at $826K in Q1 2015.
- 849 funds tracked by Wall St. Rank held GSK as of Q4 2024.
Based on Bison Wealth's 13F filing for Q4 2024, filed 14 Feb 2025.